Europe and Nasa are right to shoot for the stars
The success of two moonshot programmes should not be judged just by commercial criteria.
| Change | ||
| S&P/ASX Sm. Ords. | |||
| All Ordinaries | |||
| S&P/ASX 100 |
| ODA | ORCODA LIMITED | 11.5¢ | 167% |
| T3D | 333D LIMITED | 5.0¢ | 42.9% |
| NX1 | NEXALIS THERAPEUTICS LTD | 1.8¢ | 38.5% |
| JDO | JUDO CAPITAL HOLDINGS LIMITED | 94.3¢ | 38.6% |
| MFD | MAYFIELD CHILDCARE LIMITED | 16.0¢ | 33.3% |
| NMT | NEOMETALS LTD | 2.0¢ | 28.6% |